For a general review of the disease itself, current medical consensus highlights several key areas:

In scientific contexts, "MR" stands for Mendelian Randomization, a method used to avoid common research pitfalls like confounding factors or reverse causality. Researchers use this to identify protein associations and potential therapeutic targets for malignancies, such as B-cell leukemia. Scientific Review of "MR Validity" in Leukemia

: Recent reviews indicate that MR models have approximately 70% accuracy in predicting effective drug targets.